Pfizer boosts cancer drug roster with $14 billion Medivation deal
Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company`s growing oncology roster.
Aug 23, 2016, 09:37 AM IST
Pfizer approaches Medivation about potential takeover
Pfizer Inc has approached U.S. cancer drug maker Medivation Inc to express interest in an acquisition, raising the possibility of a bid rivaling a $9.3 billion offer by Sanofi SA, people familiar with the matter said on Tuesday.
May 04, 2016, 09:01 AM IST![Pfizer and Allergan scrap $160 billion "inversion" deal](https://english.cdn.zeenews.com/sites/default/files/styles/zm_700x400/public/2016/04/06/476483-pfizer740.jpg "Pfizer and Allergan scrap $160 billion "inversion" deal")
Pfizer and Allergan scrap $160 billion "inversion" deal
US drugmaker Pfizer Inc and Ireland-based Allergan Plc formally announced the scrapping of their $160 billion merger on Wednesday, in a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.
Apr 06, 2016, 17:29 PM IST
Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says
Drugmakers Pfizer Inc and Allergan Plc will mutually terminate their merger early Wednesday morning, according to a source familiar with the matter.
Apr 06, 2016, 09:32 AM IST
Pfizer-Allergan $160 bn deal: Interesting facts and outcomes
Let's take a look at some of the interesting facts from the record USD 160 billion deal.
Nov 23, 2015, 23:22 PM IST
Pfizer to buy Allergan in $160 bn deal to create world's biggest drugmaker
Pfizer Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan in a transaction valued at about $160 billion, creating the world's biggest drugmaker.
Nov 23, 2015, 11:46 AM IST
Investors seek protection against healthcare stock decline
Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.
Apr 25, 2015, 01:45 AM IST
U.S. multinationals hit hard by strong dollar, to bleed further into 2015
A slew of U.S. multinational companies, from DuPont to Procter & Gamble, showed that a strong U.S. dollar hurt their earnings, and several blue-chip exporters said the situation will get worse if the greenback holds its strength.
Jan 28, 2015, 04:40 AM IST
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor
Pfizer Inc and India`s Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor.
Sep 13, 2014, 11:08 AM IST
